HSBC Holdings’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADCT
ACM
OM
HSBC Holdings's ADCT Position: Q3 2026 in Review
HSBC Holdings opened a new position in ADC Therapeutics (ADCT) in Q3 2026: 16,660 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #2859 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in ADCT as recently as Q1 2026.
HSBC Holdings first reported a position in ADCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $41.6K in Q3 2025. 110 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.
- HSBC Holdings held 16,660 shares of ADC Therapeutics worth $21K as of Q3 2026.
- ADC Therapeutics was a new HSBC Holdings position in Q3 2026.
- ADC Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2859 holding.
- HSBC Holdings first reported a position in ADC Therapeutics in Q3 2025 and has held it in 4 quarters since.
- HSBC Holdings's ADC Therapeutics position peaked at $41.6K in Q3 2025.
- 110 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.